Return to homepagePandemic Pact

Developing a SARS-CoV-2 antigen test using either Spike-1 (S1) or Nucleocapsid (N) antibodies

  • Funded by Department of Science and Innovation - South Africa, Technology Innovation Agency
  • Total publications:0 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $183,422.75

  • Funder

    Department of Science and Innovation - South Africa, Technology Innovation Agency

  • Research Location

    South Africa

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract